Multiplexed immunofluorescence reveals protein expression alterations in breast cancer

Breast cancers are highly variable and the specific characteristics of a tumor determine treatment response and patient outcome. Genetic sequencing has improved our understanding of the genetic changes that underlie cancer phenotypes; however, less is known about differences in protein expression among breast cancers.

A new study in JCI Insight reports the use of a multiplexed immunostaining platform to examine the within . Research teams led by Ingo Mellinghoff and Steven Larsen of Memorial Sloan Kettering Cancer Center, and Fiona Ginty of GE Global Research evaluated expression of 27 proteins in single cells within paraffin-fixed sections from patients with untreated stage II/III .

The researchers identified 8 clusters of proteins that were co-expressed within cancer cells. A third of the breast tumors expressed only one of the 8 clusters, while the remaining tumors contained multiple protein co-expression clusters that occurred in discrete and interspersed patterns.

These results indicate that multiplexed immunofluorescence is a useful technique to interrogate cell populations and signaling networks within a tumor to enhance our understanding of tumor biology.

More information: Anup Sood et al, Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism, JCI Insight (2016). DOI: 10.1172/jci.insight.87030

Citation: Multiplexed immunofluorescence reveals protein expression alterations in breast cancer (2016, May 5) retrieved 26 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Two known chemotherapy agents effectively target breast cancer stem cells


Feedback to editors